Health Condition 1: null- Khafqan (Plapitation) Health Condition 2: R002- Palpitations
Conditions
Interventions
Intervention1: Khamira-e-Abresham Saada: Khamira Abresham Saada Semi solid Oral 5 gm Twice daily for two weeks
Control Intervention1: Nil: Nil
Sponsors
Central Council For Research In Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex in the age group of 19-60 2. Patients having Palpitations with/without Ordinary physical activity with and without any of the followingsymptoms/ signs: Ghabrahat Sweating Nausea Vomiting Missed Heart Beat Sensation Fullness in chest Shortness of Breath
Exclusion criteria
Exclusion criteria: 1. History of any heart diseases 2. History of Hepatic, Renal disorders, Diabetes Mellitus, Hypertension, Anaemia, COPD 3. History of thyroid dysfunction 4. History of hypersensitivity to any ingredient of the study drug. 5. Participants with history of long term use of any other drugs such as anti-epileptic, anti-arrhythmicand anti-psychotic drugs etc. 6. History of Addiction (smoking, alcohol, drugs) 7. Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in the sign and symptoms of Khafqan (Plapitation)Timepoint: Two Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Hematological and biochemical assessments for safetyTimepoint: two weeks | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed